Scienture Holdings, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its liquid formulation of losartan, branded as ArbliTM (losartan potassium) Oral Suspension, at a ...
Scienture's Arbli losartan oral suspension gains access to over 100 million covered lives through national commercial and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback